[CLS] O
Selegiline O
- O
induced O
postural B
hypotension I
in O
Parkinson B
' I
s I
disease I
: O
a O
longitudinal O
study O
on O
the O
effects O
of O
drug O
withdrawal O
. O
[SEP] O

[CLS] O
CONCLUSION O
: O
This O
study O
confirms O
our O
previous O
finding O
that O
selegiline O
in O
combination O
with O
L O
- O
dopa O
is O
associated O
with O
selective O
orthostatic B
hypotension I
. O
[SEP] O

[CLS] O
In O
the O
in O
vivo O
study O
, O
the O
administration O
( O
50 O
mg O
/ O
kg O
, O
i O
. O
p O
. O
) O
of O
TET O
and O
FAN O
in O
mice O
showed O
the O
inhibition O
of O
thrombosis B
by O
55 O
% O
and O
35 O
% O
, O
respectively O
, O
while O
acetylsalicylic O
acid O
( O
ASA O
, O
50 O
mg O
/ O
kg O
, O
i O
. O
p O
. O
) O
, O
a O
positive O
control O
, O
showed O
only O
30 O
% O
inhibition O
. O
[SEP] O

[CLS] O
The O
prevalence O
rate O
for O
CIMD B
was O
12 O
% O
at O
baseline O
. O
[SEP] O

[CLS] O
Recent O
reports O
indicate O
that O
single O
agent O
therapy O
with O
vinorelbine O
( O
VNB O
) O
or O
gemcitabine O
( O
GEM O
) O
may O
obtain O
a O
response O
rate O
of O
20 O
- O
30 O
% O
in O
elderly O
patients O
, O
with O
acceptable O
toxicity B
and O
improvement O
in O
symptoms O
and O
quality O
of O
life O
. O
[SEP] O

[CLS] O
Warfarin O
- O
induced O
artery B
calcification I
is O
accelerated O
by O
growth O
and O
vitamin O
D O
. O
[SEP] O

[CLS] O
High O
doses O
of O
vitamin O
D O
are O
known O
to O
cause O
calcification B
of I
the I
artery I
media O
in O
as O
little O
as O
3 O
to O
4 O
days O
. O
[SEP] O

[CLS] O
Tamoxifen O
( O
TAM O
) O
, O
the O
antiestrogenic O
drug O
most O
widely O
prescribed O
in O
the O
chemotherapy O
of O
breast B
cancer I
, O
induces O
changes O
in O
normal O
discoid O
shape O
of O
erythrocytes O
and O
hemolytic B
anemia I
. O
[SEP] O

